.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A randomized study evaluated whether serial procalcitonin measurements could help shorten antibiotic therapy in patients with severe sepsis and septic shock. In patients managed with a procalcitonin algorithm, antibiotic exposure was reduced compared with empirical treatment decisions, without an apparent increase in mortality or recurrence of the primary infection. The study contributed to the evidence supporting biomarker-assisted antimicrobial stewardship in critical care. For general physicians, however, procalcitonin should be viewed as an adjunct rather than an autonomous prescribing signal. Clinical stability, microbiology, source control, imaging and the patient's immune status remain essential. The broader value of the biomarker is in helping clinicians question unnecessary continuation of antibiotics when the clinical trajectory supports de-escalation. This is especially relevant in settings facing antimicrobial resistance. Protocolized use can improve consistency, but local epidemiology and resource availability matter. The practical lesson is that biomarkers work best when embedded in clinical decision algorithms rather than interpreted in isolation.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized study evaluated whether serial procalcitonin measurements could help shorten antibiotic therapy in patients with severe sepsis and septic shock. In patients managed with a procalcitonin algorithm, antibiotic exposure was reduced compared with empirical treatment decisions, without an apparent increase in mortality or recurrence of the primary infection. The study contributed to the evidence supporting biomarker-assisted antimicrobial stewardship in critical care. For general physicians, however, procalcitonin should be viewed as an adjunct rather than an autonomous prescribing signal. Clinical stability, microbiology, source control, imaging and the patient's immune status remain essential. The broader value of the biomarker is in helping clinicians question unnecessary continuation of antibiotics when the clinical trajectory supports de-escalation. This is especially relevant in settings facing antimicrobial resistance. Protocolized use can improve consistency, but local epidemiology and resource availability matter. The practical lesson is that biomarkers work best when embedded in clinical decision algorithms rather than interpreted in isolation.
3 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
